Lentechs Announces Preliminary Results in Milestone Clinical Trial Evaluating its Investigational Contact Lens for Patients with Presbyopia

- Patients with presbyopia and presbyopia with astigmatism reported clinically meaningful and statistically superior distance vision for its investigational contact lens APIOC™ (pronunciation: AP•EE•OCK) over their habitual multifocal contact lenses, while having similar intermediate and near visual acuity

- Patients habitually wearing prescription glasses for their presbyopia and presbyopia with astigmatism reported comparable vision at distance, intermediate, and near with APIOC

COLUMBUS, Ohio, Nov. 11, 2021 /PRNewswire/ -- Lentechs, a clinical-stage ophthalmic medical device company developing a new generation of soft, suspended contact lens, designed to transform the treatment paradigm for presbyopia, today announced key results in a milestone clinical trial evaluating its investigational contact lens for patients with presbyopia and presbyopia with astigmatism. Click here to read the rest of the press release.

Additionally, the company posted this to their LinkedIn channel which you can view here.

Shared by Tyler Stowater, board member of Lentechs LLC